Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).
      QxMD      Google Scholar   
Citation:
J Pain Symptom Manage vol 43 (2) 205-17
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
632  
Children:
None
Program:
CCP
Primary Committee:
Health Outcomes
Sec. Committees:
   
Pharmas:
 
Grants:
CA03927, CA04326, CA04457, CA08025, CA114558-02, CA11789, CA12046, CA164504, CA21060, CA26806, CA29165, CA32291, CA35421, CA37135, CA41287, CA45389, CA45418, CA45564, CA45808, CA47559, CA47577, CA47642, CA59518, CA74811, CA77298, CA77406, CA77440, CA77597, CA77651, CA77658, CA86726, U10 CA003927, U10 CA004457, U10 CA008025, U10 CA011789, U10 CA012046, U10 CA016450, U10 CA021060, U10 CA032291, U10 CA035421, U10 CA037447, U10 CA041287, U10 CA045389, U10 CA045564, U10 CA045808, U10 CA047559, U10 CA047577, U10 CA047642, U10 CA059518, U10 CA067663, U10 CA074811, U10 CA077298, U10 CA077440, U10 CA077597, U10 CA077651, U10 CA077658, U10 CA086726, U10 CA114558  
Corr. Author:
 
Authors:
               
Networks:
 
Study
CALGB-80303
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Aged, Aged, 80 and over, Antimetabolites, Antineoplastic, Deoxycytidine, Double-Blind Method, Female, Humans, Male, Middle Aged, Pain, Palliative Care, Pancreatic Neoplasms, Prevalence, Quality of Life, Risk Assessment, Risk Factors, Survival Analysis, Survival Rate, Treatment Outcome, United States